Methods and compositions for treating leukemia

Details for Australian Patent Application No. 2010282547 (hide)

Owner Novartis AG The University Court of the University of Glasgow

Inventors Copland, Mhairi; Dorsch, Marion; Irvine, David; Manley, Paul W.; Peukert, Stefan

Agent Davies Collison Cave

Pub. Number AU-A-2010282547

PCT Pub. Number WO2011/019798

Priority 12/539,855 12.08.09 US

Filing date 11 August 2010

Wipo publication date 17 February 2011

International Classifications

A61P 35/02 (2006.01) Antineoplastic agents

A61K 31/4433 (2006.01)

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

Event Publications

16 February 2012 PCT application entered the National Phase

  PCT publication WO2011/019798 Priority application(s): WO2011/019798

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010282550-Cathepsin C inhibitors

2010282537-Tidal responsive barrier